Central nervous system granulomatous angiitis as a paraneoplastic disorder in Hodgkin's lymphoma in the age of immune checkpoint inhibitor therapy

Key Points

• Central nervous system granulomatous angiitis occurs in Hodgkin's lymphoma cases related to immune checkpoint inhibitors, indicating a rare paraneoplastic disorder.
• Case evaluations identified granulomatous angiitis in patients with Hodgkin's lymphoma undergoing immune therapy, highlighting a potential disease association.
• The analysis focuses on rare neurological complications linked with hodgkin's lymphoma and immune checkpoint inhibitors, emphasizing the relevance of monitoring symptoms.
• This highlights the need for awareness of neurological adverse effects in immunotherapies, signaling possible risks for Hodgkin's lymphoma patients.